{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:06:11Z","timestamp":1784091971456,"version":"3.55.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bowel Cancer Australia"},{"DOI":"10.13039\/501100001047","name":"Ian Potter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1186\/s12014-026-09608-1","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:52:41Z","timestamp":1778478761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic biomarkers of distant metastasis following curative-intent resection of early-stage rectal cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Vo Van Anh","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita C.Y.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Hoong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"9608_CR1","unstructured":"AIHW. Cancer data in Australia. Canberra: AIHW; 2023."},{"key":"9608_CR2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209\u2009\u2013\u200949.","DOI":"10.3322\/caac.21660"},{"key":"9608_CR3","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK et al. AJCC Cancer Staging Manual: Springer International Publishing; 2018."},{"issue":"2","key":"9608_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00384-021-04083-6","volume":"37","author":"WJ Lossius","year":"2022","unstructured":"Lossius WJ, Stornes T, Myklebust TA, Endreseth BH, Wibe A. Completion surgery vs. primary TME for early rectal cancer: a national study. Int J Colorectal Dis. 2022;37(2):429\u201335.","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"9608_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clon.2022.08.030","volume":"35","author":"C Cunningham","year":"2023","unstructured":"Cunningham C. Local Excision for Early Rectal Cancer. Clin Oncol. 2023;35(2):82\u20136.","journal-title":"Clin Oncol"},{"issue":"9","key":"9608_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/bjs.8821","volume":"99","author":"E Lezoche","year":"2012","unstructured":"Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012;99(9):1211\u20138.","journal-title":"Br J Surg"},{"issue":"2","key":"9608_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2468-1253(20)30333-2","volume":"6","author":"SP Bach","year":"2021","unstructured":"Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, et al. Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study. Lancet Gastroenterol Hepatol. 2021;6(2):92\u2013105.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"9608_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/DCR.0000000000001762","volume":"63","author":"YN You","year":"2020","unstructured":"You YN, Hardiman KM, Bafford A, Poylin V, Francone TD, Davis K, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Rectal Cancer. Dis Colon Rectum. 2020;63(9):1191\u2013222.","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 4","key":"9608_CR9","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","volume":"29","author":"R Glynne-Jones","year":"2018","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263.","journal-title":"Ann Oncol"},{"issue":"1","key":"9608_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","volume":"25","author":"Y Hashiguchi","year":"2020","unstructured":"Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25(1):1\u201342.","journal-title":"Int J Clin Oncol"},{"issue":"Suppl 1","key":"9608_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/codi.13705","volume":"19","author":"S Gollins","year":"2017","unstructured":"Gollins S, Moran B, Adams R, Cunningham C, Bach S, Myint AS, et al. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Multidisciplinary Management. Colorectal Dis. 2017;19(Suppl 1):37\u201366.","journal-title":"Colorectal Dis"},{"issue":"4","key":"9608_CR12","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.21037\/tcr.2020.02.43","volume":"9","author":"L Ji","year":"2020","unstructured":"Ji L, Gu L, Zhang X, Wang J. Evaluation of serum midkine and carcinoembryonic antigen as diagnostic biomarkers for rectal cancer and synchronous metastasis. Transl Cancer Res. 2020;9(4):2814\u201323.","journal-title":"Transl Cancer Res"},{"issue":"1","key":"9608_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1186\/s12885-023-11354-8","volume":"23","author":"B Guan","year":"2023","unstructured":"Guan B, Xu M, Zheng R, Guan G, Xu B. Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy. BMC Cancer. 2023;23(1):1099.","journal-title":"BMC Cancer"},{"key":"9608_CR14","doi-asserted-by":"publisher","first-page":"216145","DOI":"10.1016\/j.canlet.2023.216145","volume":"562","author":"K Xu","year":"2023","unstructured":"Xu K, Yin X, Zhou B, Zheng X, Wang H, Chen J, et al. FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients. Cancer Lett. 2023;562:216145.","journal-title":"Cancer Lett"},{"issue":"1","key":"9608_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"issue":"5","key":"9608_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1200\/JCO.23.01208","volume":"42","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, et al. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. J Clin Oncol. 2024;42(5):500\u20136.","journal-title":"J Clin Oncol"},{"issue":"5795","key":"9608_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960\u20134.","journal-title":"Science"},{"issue":"19","key":"9608_CR18","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-20-0337","volume":"26","author":"C El Sissy","year":"2020","unstructured":"El Sissy C, Kirilovsky A, Van den Eynde M, Mu\u015fin\u0103 AM, Anitei MG, Romero A, et al. A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy. Clin Cancer Res. 2020;26(19):5198\u2013207.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9608_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.23.00586","volume":"42","author":"C El Sissy","year":"2024","unstructured":"El Sissy C, Kirilovsky A, Lagorce Pag\u00e8s C, Marliot F, Custers PA, Dizdarevic E, et al. International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy. J Clin Oncol. 2024;42(1):70\u201380.","journal-title":"J Clin Oncol"},{"issue":"10135","key":"9608_CR20","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F Pag\u00e8s","year":"2018","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391(10135):2128\u201339.","journal-title":"Lancet"},{"issue":"6928","key":"9608_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198\u2013207.","journal-title":"Nature"},{"issue":"6","key":"9608_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14789450.2019.1615452","volume":"16","author":"L Giusti","year":"2019","unstructured":"Giusti L, Angeloni C, Lucacchini A. Update on proteomic studies of formalin-fixed paraffin-embedded tissues. Expert Rev Proteom. 2019;16(6):513\u201320.","journal-title":"Expert Rev Proteom"},{"issue":"2","key":"9608_CR23","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1021\/acs.jproteome.0c00693","volume":"20","author":"P Steffen","year":"2021","unstructured":"Steffen P, Li J, Chandra J, Ahadi MS, Gill AJ, Engel AF, et al. Molecular Features of Lymph Node Metastasis in T1\/2 Colorectal Cancer from Formalin-Fixed Paraffin-Embedded Archival Specimens. J Proteome Res. 2021;20(2):1304\u201312.","journal-title":"J Proteome Res"},{"issue":"5","key":"9608_CR24","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1021\/acs.jproteome.9b00090","volume":"18","author":"DJ Harney","year":"2019","unstructured":"Harney DJ, Hutchison AT, Hatchwell L, Humphrey SJ, James DE, Hocking S, et al. Proteomic Analysis of Human Plasma during Intermittent Fasting. J Proteome Res. 2019;18(5):2228\u201340.","journal-title":"J Proteome Res"},{"issue":"1","key":"9608_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17(1):41\u20134.","journal-title":"Nat Methods"},{"issue":"D1","key":"9608_CR26","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"The UniProt C","year":"2023","unstructured":"The UniProt C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523\u201331.","journal-title":"Nucleic Acids Res"},{"key":"9608_CR27","doi-asserted-by":"crossref","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences. 2005;102(43):15545-50.","DOI":"10.1073\/pnas.0506580102"},{"issue":"1","key":"9608_CR28","doi-asserted-by":"publisher","first-page":"2238506","DOI":"10.1080\/2162402X.2023.2238506","volume":"12","author":"BCY Tse","year":"2023","unstructured":"Tse BCY, Bergamin S, Steffen P, Hruby G, Pavlakis N, Clarke SJ, et al. CD11c\u2009+\u2009and IRF8\u2009+\u2009cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy. OncoImmunology. 2023;12(1):2238506.","journal-title":"OncoImmunology"},{"issue":"1","key":"9608_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-020-01618-6","volume":"18","author":"W Xu","year":"2020","unstructured":"Xu W, He Y, Wang Y, Li X, Young J, Ioannidis JPA, et al. Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):172.","journal-title":"BMC Med"},{"issue":"5","key":"9608_CR30","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/den.14220","volume":"34","author":"K Ichimasa","year":"2022","unstructured":"Ichimasa K, Kudo SE, Miyachi H, Kouyama Y, Mochizuki K, Takashina Y, et al. Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review. Dig Endosc. 2022;34(5):901\u201312.","journal-title":"Dig Endosc"},{"issue":"12","key":"9608_CR31","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1177\/00031348221146975","volume":"89","author":"S Ishikawa","year":"2022","unstructured":"Ishikawa S, Hirano Y, Deguchi K, Ishii T, Ishiyama Y, Okazaki N, et al. Risk Factors for Lymph Node Metastasis and Recurrence in T1 Colorectal Cancer: Analysis of 801 Patients in a Single Institute. Am Surgeon\u2122. 2022;89(12):5312\u20137.","journal-title":"Am Surgeon\u2122"},{"issue":"1","key":"9608_CR32","doi-asserted-by":"publisher","first-page":"22133","DOI":"10.1038\/s41598-024-73496-4","volume":"14","author":"C Yu","year":"2024","unstructured":"Yu C, Shi Z, Zhou G, Chang X. Revisiting the survival paradox between stage IIB\/C and IIIA colon cancer. Sci Rep. 2024;14(1):22133.","journal-title":"Sci Rep"},{"key":"9608_CR33","doi-asserted-by":"crossref","unstructured":"Yothers G, Venook AP, Yamanaka T, Lin Y, Crager M, Chao CY et al. Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin. J Clin Oncol.39(15_suppl):3599-.","DOI":"10.1200\/JCO.2021.39.15_suppl.3599"},{"issue":"24","key":"9608_CR34","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1200\/JCO.2016.67.0414","volume":"34","author":"T Yamanaka","year":"2016","unstructured":"Yamanaka T, Oki E, Yamazaki K, Yamaguchi K, Muro K, Uetake H, et al. 12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II\/III Colon Cancer With Surgery Alone: The SUNRISE Study. J Clin Oncol. 2016;34(24):2906\u201313.","journal-title":"J Clin Oncol"},{"issue":"2","key":"9608_CR35","first-page":"1388","volume":"18","author":"K Kumamoto","year":"2019","unstructured":"Kumamoto K, Nakachi Y, Mizuno Y, Yokoyama M, Ishibashi K, Kosugi C, et al. Expressions of 10 genes as candidate predictors of recurrence in stage III colon cancer patients receiving adjuvant oxaliplatin-based chemotherapy. Oncol Lett. 2019;18(2):1388\u201394.","journal-title":"Oncol Lett"},{"issue":"11","key":"9608_CR36","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"issue":"7","key":"9608_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/1878-0261.12096","volume":"11","author":"TT Liao","year":"2017","unstructured":"Liao TT, Yang MH. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. Mol Oncol. 2017;11(7):792\u2013804.","journal-title":"Mol Oncol"},{"issue":"12","key":"9608_CR38","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15(12):1243\u201353.","journal-title":"EMBO Rep"},{"key":"9608_CR39","doi-asserted-by":"crossref","unstructured":"Song K, Yu Z, Zu X, Li G, Hu Z, Xue Y. Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment. Int J Mol Sci. 2022;23(18).","DOI":"10.3390\/ijms231810509"},{"issue":"1","key":"9608_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13578-019-0361-4","volume":"9","author":"Z Koveitypour","year":"2019","unstructured":"Koveitypour Z, Panahi F, Vakilian M, Peymani M, Seyed Forootan F, Nasr Esfahani MH, et al. Signaling pathways involved in colorectal cancer progression. Cell Bioscience. 2019;9(1):97.","journal-title":"Cell Bioscience"},{"key":"9608_CR41","doi-asserted-by":"crossref","unstructured":"He L, Kang Q, Chan KI, Zhang Y, Zhong Z, Tan W. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer. Front Immunol. 2023;13.","DOI":"10.3389\/fimmu.2022.1093990"},{"key":"9608_CR42","doi-asserted-by":"publisher","first-page":"107327482412354","DOI":"10.1177\/10732748241235468","volume":"31","author":"GS Li","year":"2024","unstructured":"Li GS, Tang YX, Zhang W, Li JD, Huang HQ, Liu J, et al. MMP12 is a Potential Predictive and Prognostic Biomarker of Various Cancers Including Lung Adenocarcinoma. Cancer Control. 2024;31:10732748241235468.","journal-title":"Cancer Control"},{"key":"9608_CR43","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12885-016-2515-7","volume":"16","author":"F Klupp","year":"2016","unstructured":"Klupp F, Neumann L, Kahlert C, Diers J, Halama N, Franz C, et al. Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients. BMC Cancer. 2016;16:494.","journal-title":"BMC Cancer"},{"key":"9608_CR44","doi-asserted-by":"publisher","first-page":"105572","DOI":"10.1016\/j.biocel.2019.105572","volume":"114","author":"Y Xie","year":"2019","unstructured":"Xie Y, Liu C, Qin Y, Chen J, Fang J. Knockdown of IRE1\u0251 suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src\/FAK-GTPases signaling. Int J Biochem Cell Biol. 2019;114:105572.","journal-title":"Int J Biochem Cell Biol"},{"key":"9608_CR45","doi-asserted-by":"publisher","first-page":"925165","DOI":"10.3389\/fonc.2022.925165","volume":"12","author":"YH Wu","year":"2022","unstructured":"Wu YH, Chou CY, Collagen XI. Alpha 1 Chain, a Novel Therapeutic Target for Cancer Treatment. Front Oncol. 2022;12:925165.","journal-title":"Front Oncol"},{"issue":"4","key":"9608_CR46","first-page":"3727","volume":"18","author":"S Duan","year":"2018","unstructured":"Duan S, Gong B, Wang P, Huang H, Luo L, Liu F. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG. Mol Med Rep. 2018;18(4):3727\u201336.","journal-title":"Mol Med Rep"},{"issue":"6","key":"9608_CR47","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1002\/jcb.26651","volume":"119","author":"X Cai","year":"2018","unstructured":"Cai X, Liu C, Zhang T-N, Zhu Y-W, Dong X, Xue P. Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion. J Cell Biochem. 2018;119(6):4717\u201328.","journal-title":"J Cell Biochem"},{"key":"9608_CR48","doi-asserted-by":"publisher","first-page":"913659","DOI":"10.3389\/fgene.2022.913659","volume":"13","author":"XX Zhang","year":"2022","unstructured":"Zhang XX, Luo JH, Wu LQ. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Front Genet. 2022;13:913659.","journal-title":"Front Genet"},{"key":"9608_CR49","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.2147\/IJGM.S364708","volume":"15","author":"WH Zhou","year":"2022","unstructured":"Zhou WH, Du WD, Li YF, Al-Aroomi MA, Yan C, Wang Y, et al. The Overexpression of Fibronectin 1 Promotes Cancer Progression and Associated with M2 Macrophages Polarization in Head and Neck Squamous Cell Carcinoma Patients. Int J Gen Med. 2022;15:5027\u201342.","journal-title":"Int J Gen Med"},{"key":"9608_CR50","doi-asserted-by":"crossref","unstructured":"Hill CN, Hern\u00e1ndez-C\u00e1ceres MP, Asencio C, Torres B, Solis B, Owen GI. Deciphering the Role of the Coagulation Cascade and Autophagy in Cancer-Related Thrombosis and Metastasis. Front Oncol. 2020;10.","DOI":"10.3389\/fonc.2020.605314"},{"key":"9608_CR51","doi-asserted-by":"crossref","unstructured":"Salman T, Bilici A, Arslan C, Varol U, Yildiz I, Akyol M et al. Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1\u2009+\u20092 levels in patients with advanced colorectal cancer. J Clin Oncol.34(4_suppl):615-.","DOI":"10.1200\/jco.2016.34.4_suppl.615"},{"issue":"2","key":"9608_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.currproblcancer.2018.01.009","volume":"42","author":"HT Mohamed","year":"2018","unstructured":"Mohamed HT, El-Husseiny N, El-Ghonaimy EA, Ibrahim SA, Bazzi ZA, Cavallo-Medved D, et al. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages. Curr Probl Cancer. 2018;42(2):215\u201330.","journal-title":"Curr Probl Cancer"},{"issue":"10","key":"9608_CR53","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41401-022-00894-7","volume":"43","author":"S Li","year":"2022","unstructured":"Li S, Yang H, Li W, Liu J-y, Ren L-w, Yang Y-h, et al. ADH1C inhibits progression of colorectal cancer through the ADH1C\/PHGDH \/PSAT1\/serine metabolic pathway. Acta Pharmacol Sin. 2022;43(10):2709\u201322.","journal-title":"Acta Pharmacol Sin"},{"key":"9608_CR54","doi-asserted-by":"publisher","first-page":"114691","DOI":"10.1016\/j.bcp.2021.114691","volume":"192","author":"F Song","year":"2021","unstructured":"Song F, Zhang Y, Pan Z, Hu X, Zhang Q, Huang F, et al. The role of alcohol dehydrogenase 1\u00a0C in regulating inflammatory responses in ulcerative colitis. Biochem Pharmacol. 2021;192:114691.","journal-title":"Biochem Pharmacol"},{"key":"9608_CR55","doi-asserted-by":"crossref","unstructured":"Li X, Wu Y, Tian T. TGF-\u03b2 Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development. Int J Mol Sci. 2022;23(22).","DOI":"10.3390\/ijms232214436"},{"issue":"1","key":"9608_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-020-01174-w","volume":"19","author":"J Xu","year":"2020","unstructured":"Xu J, Shao T, Song M, Xie Y, Zhou J, Yin J, et al. MIR22HG acts as a tumor suppressor via TGF\u03b2\/SMAD signaling and facilitates immunotherapy in colorectal cancer. Mol Cancer. 2020;19(1):51.","journal-title":"Mol Cancer"},{"issue":"11","key":"9608_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12032-023-02204-5","volume":"40","author":"S Singh","year":"2023","unstructured":"Singh S, Gouri V, Samant M. TGF-\u03b2 in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer. Med Oncol. 2023;40(11):335.","journal-title":"Med Oncol"},{"issue":"5","key":"9608_CR58","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390.","journal-title":"Cancer Cell"},{"key":"9608_CR59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massagu\u00e9 J. TGF-\u03b2 in developmental and fibrogenic EMTs. Sem Cancer Biol. 2022;86:136\u201345.","journal-title":"Sem Cancer Biol"},{"issue":"3","key":"9608_CR60","first-page":"189316","volume":"1880","author":"R Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a R, Baulida J. Snail1 as a key prognostic biomarker of cancer-associated fibroblasts in breast tumors. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2025;1880(3):189316.","journal-title":"Reviews Cancer"},{"issue":"1","key":"9608_CR61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1383-5742(03)00033-4","volume":"566","author":"J Gotzmann","year":"2004","unstructured":"Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res. 2004;566(1):9\u201320.","journal-title":"Mutat Res"},{"issue":"5","key":"9608_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","volume":"17","author":"MA Huber","year":"2005","unstructured":"Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17(5):548\u201358.","journal-title":"Curr Opin Cell Biol"},{"issue":"29","key":"9608_CR63","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1200\/JCO.23.02030","volume":"42","author":"CJM Williams","year":"2024","unstructured":"Williams CJM, Gray R, Hills RK, Shires M, Zhang L, Zhao Z, et al. Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial. J Clin Oncol. 2024;42(29):3430\u201342.","journal-title":"J Clin Oncol"},{"issue":"2","key":"9608_CR64","doi-asserted-by":"publisher","first-page":"2200263","DOI":"10.1002\/adbi.202200263","volume":"7","author":"H Li","year":"2023","unstructured":"Li H, Xie P, Li P, Du Y, Zhu J, Yuan Y, et al. CD73\/NT5E is a Potential Biomarker for Cancer Prognosis and Immunotherapy for Multiple Types of Cancers. Adv Biology. 2023;7(2):2200263.","journal-title":"Adv Biology"},{"issue":"4","key":"9608_CR65","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jcmgh.2022.07.005","volume":"14","author":"J-Y Noh","year":"2022","unstructured":"Noh J-Y, Lee IP, Han NR, Kim M, Min YK, Lee S-Y, et al. Additive Effect of CD73 Inhibitor in Colorectal Cancer Treatment With CDK4\/6 Inhibitor Through Regulation of PD-L1. Cell Mol Gastroenterol Hepatol. 2022;14(4):769\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"8","key":"9608_CR66","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","volume":"16","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015;16(8):957\u201366.","journal-title":"Lancet Oncol"},{"issue":"10","key":"9608_CR67","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","volume":"35","author":"T Conroy","year":"2024","unstructured":"Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873\u201381.","journal-title":"Ann Oncol"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-026-09608-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-026-09608-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:25:38Z","timestamp":1784089538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12014-026-09608-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9608"],"URL":"https:\/\/doi.org\/10.1186\/s12014-026-09608-1","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approved by Northern Sydney Local Health District Human Research Ethics Committee (2021\/ETH00600), which included a waiver of patient consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"37"}}